Evommune EVMN Unrealized Loss On Issuance Of Preferred Stock
Unrealized Loss On Issuance Of Preferred Stock at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept meha:UnrealizedLossOnIssuanceOfPreferredStock.
The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's unrealized loss on issuance of preferred stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evommune 's unrealized loss on issuance of preferred stock?
- Evommune (EVMN) reported unrealized loss on issuance of preferred stock of $6.31M in Q1 2026.
- How has Evommune 's unrealized loss on issuance of preferred stock changed year-over-year?
- Evommune 's unrealized loss on issuance of preferred stock increased by 376.8% year-over-year, from $1.32M to $6.31M.
- What does unrealized loss on issuance of preferred stock mean?
- Captures the non-cash accounting loss recognized upon the issuance of preferred stock, typically due to the fair value measurement of embedded derivatives or conversion features. This highlights the impact of complex capital structures on the company's reported net income.